Because the structural spike (S) protein triggers the infection of the target cell, as the SARS-CoV-2 virus penetrates the cell via the attachment of the S protein to cellular receptors known as human angiotensin-converting enzyme 2 (ACE2), it is considered the most promising target for vaccine development against COVID-19 infection [2–4]. Here, ACE2 is linked to infection.